Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients

Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients

Type 2 Diabetes Mellitus (T2DM) is the most common form of diabetes mellitus and accounts for about 95% of all diabetes cases. Many newer oral as well as parenteral antidiabetic drugs have been introduced in to the market in recent years to control hyperglycemic conditions in diabetes patients and m...

Full description

Bibliographic Details
Main Authors: Sivanandy Palanisamy, Emily Lau Hie Yien, Ling Wen Shi, Low Yi Si, See Hui Qi, Laura Soon Cheau Ling, Teng Wai Lun, Yap Nee Chen
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:Pharmacy
Subjects:
diabetes mellitus
antidiabetic agent
efficacy
safety
glycosylated hemoglobin
Online Access:http://www.mdpi.com/2226-4787/6/3/57

Internet

http://www.mdpi.com/2226-4787/6/3/57

Similar Items